Investor Relations

Stock price graph
     

Exact Sciences is a molecular diagnostics company focused on colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Stool-based DNA (sDNA) technology is included in the colorectal cancer screening guidelines of the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer.

PDF 2013 Annual Report [ 4.4 MB]

Recent Releases

Oct 20, 2014
Exact Sciences to Host Third-Quarter 2014 Results Webcast and Call

Oct 9, 2014
Exact Sciences Announces Final National Coverage Determination for Cologuard®

Sep 22, 2014
Exact Sciences Announces Group Health Cooperative as First Health Plan in Wisconsin to Cover Cologuard®

View all releases »

Events & Presentations

Oct 27, 2014 at 10:00 AM ET
Third-Quarter 2014 Earnings Call

View all events & presentations »

Stock Quote

Ticker:
EXAS
Exchange:
NASDAQ
Price:
23.86
Change:
+ 0.09
Volume:
2,113,600
4:00 PM ET on Oct 20, 2014
Delayed at least 20 minutes.
Provided by eSignal.

IR Search